Checkpoint kinase 1 (Chk1)-short is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints
- 19 December 2011
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (1), 197-202
- https://doi.org/10.1073/pnas.1104767109
Abstract
Checkpoint kinase 1 (Chk1) is a key regulator of checkpoint signaling in both the unperturbed cell cycle and DNA damage response. Under these conditions, Chk1 becomes active to prevent premature CDK1 activation and mitotic entry until DNA is properly replicated or repaired. It is unclear how Chk1 activity is controlled in the unperturbed cell cycle. During DNA damage, Chk1 is activated by ataxia telangiectasia and Rad3 related (ATR)-mediated phosphorylation; however, it is not entirely clear how this phosphorylation results in Chk1 activation. Here we report an N-terminally truncated alternative splice variant of Chk1, Chk1-S. Importantly, we show that Chk1-S is an endogenous repressor and regulator of Chk1. In the unperturbed cell cycle, Chk1-S interacts with and antagonizes Chk1 to promote the S-to-G2/M phase transition. During DNA damage, Chk1 is phosphorylated, which disrupts the Chk1-Chk1-S interaction, resulting in free, active Chk1 to arrest the cell cycle and facilitate DNA repair. Higher levels of Chk1-S are expressed, along with Chk1, in fetal and cancer tissues than in normal tissues. However, forced overexpression of Chk1-S in cultured cells and tumor xenografts induces premature mitotic entry, mitotic catastrophe, and reduction of tumor growth. The identification of Chk1-S as a unique splice variant and key regulator of Chk1 provides insights into cell cycle regulation and DNA damage response.Keywords
This publication has 45 references indexed in Scilit:
- hMSH2 Recruits ATR to DNA Damage Sites for Activation during DNA Damage-induced ApoptosisOnline Journal of Public Health Informatics, 2011
- RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastomaProceedings of the National Academy of Sciences of the United States of America, 2011
- Chk1 promotes replication fork progression by controlling replication initiationProceedings of the National Academy of Sciences of the United States of America, 2010
- New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling NetworkClinical Cancer Research, 2010
- Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activityOncogene, 2009
- Regulation of Chk1Cell Division, 2009
- Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication controlProceedings of the National Academy of Sciences of the United States of America, 2008
- Cross-talk between Chk1 and Chk2 in double-mutant thymocytesProceedings of the National Academy of Sciences of the United States of America, 2007
- Checkpoint kinase 1 (Chk1) is required for mitotic progression through negative regulation of polo-like kinase 1 (Plk1)Proceedings of the National Academy of Sciences of the United States of America, 2006
- Chk1 Requirement for High Global Rates of Replication Fork Progression during Normal Vertebrate S PhaseMolecular and Cellular Biology, 2006